Atlas Trials

Kristina A. Fanucci

2 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Kristina A. Fanucci

RecordFirmDate
PhII Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer (CAPELA) (NCT07222215)Kristina A. Fanucci2026-01-16
ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrine-resistant HR+/HER2-low or HER2-ultralow Metastatic Breast Cancer (NCT07198724)Kristina A. Fanucci2025-11-17

Track Kristina A. Fanucci automatically

Every clearance here is in the API, with alerts when new ones post.